novo nordisk cuts prices for its glp-1 drugs. of Ozempic, Wegovy, and Rybelsus by up to 50% Novo Nordisk to slash list
Description
Not even close
J., Linge, J
Importantly, GLP-1 only triggers insulin when blood sugar is high, which reduces the risk of hypoglycemia (dangerously low blood sugar)
Researchers began studying peptide weight loss medications in the 1970s and eventually discovered GLP-1s effects on weight and blood sugar
Bars and restaurants depend heavily on beverage sales, which usually carry far higher margins than food
Hickey, A
